Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -50.770% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a CN(CCc1nc2ccc(Cl)cc2[nH]1)Cc1nc(CC2CC2)no1
b NS(=O)(=O)c1ccc(CCNC(=O)C(=O)NCC2OCCN2S(=O)(=O)c2ccc(F)cc2)cc1
Answer: a. CN(CCc1nc2ccc(Cl)cc2[nH]1)Cc1nc(CC2CC2)no1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(CCc1nc2ccc(Cl)cc2[nH]1)Cc1nc(CC2CC2)no1
CN(CCc1nc2ccc(Cl)cc2[nH]1)Cc1nc(CC2CC2)no1
2-(6-chloro-1H-benzimidazol-2-yl)-N-[[3-(cyclopropylmethyl)-1,2,4-oxadiazol-5-yl]methyl]-N-methylethanamine